Skip to content
Intrinsic value · Buy/Sell verdict · scores — free· 1046 Indian stocks· EOD 2026-09-14
The premium analytics — yours free, no paywall

Is it undervalued? Get the verdict — free.

Intrinsic value, a Buy/Hold/Sell verdict, financial-health grade and a 14-point investability checklist for 1046 Indian stocks. The stuff other platforms lock behind a subscription — here for nothing, no login.

1002 stocks with a fair-value estimate822 with an Altman Z health scoreEOD data · 2026-09-14

Market pulse

Flows
Breadth31
Momentum38
FII flows33
52-wk highs52

Breadth weak, FII selling — caution.

Advancers / decliners
321 / 711
last session, whole universe
Above 50-DMA
38%
of 1,046 tracked stocks
FII net (latest)
−₹931 Cr
11-Sep-2026
Next big result
Symbiotec Pharmalab
21 Sept · results calendar →

Sector heat

All stocks

Your daily ritual

Watchlist

What you get on every stock — free

Intrinsic value

A blended DCF + relative fair value, with margin of safety and an undervalued/overvalued verdict.

Buy / Hold / Sell

One verdict blending quality, valuation, momentum and the latest financial trend.

Financial health

An Altman Z-score and 0–100 solvency grade — the balance-sheet risk at a glance.

Investability checklist

14 fundamental, valuation and technical checks, scored and explained.

Morning brief

All news